Jon Napitupulu

Rezolute will hit the fall investor circuit with back-to-back appearances at the Maxim Growth Summit on October 22–23, the...

Teva has signed a license and supply agreement with Prestige Biopharma to commercialize Tuznue, a biosimilar to Herceptin (trastuzumab),...

Recordati has launched the 12th Arrigo Recordati Prize with a 2026 focus on pediatric oncology, specifically sarcomas, offering a...

Lixte Biotechnology has set its fourth-quarter agenda and disclosed advanced negotiations to acquire complementary oncology assets, signaling a push...

Ligand Pharmaceuticals will host its annual Investor Day in New York on December 9, 2025, with management set to...

Iovance Biotherapeutics has granted inducement stock options for 62,790 shares to nine new non-executive hires. The options are priced...

XOMA Royalty Corporation has amended its definitive agreement to acquire LAVA Therapeutics, cutting the initial cash consideration to $1.04...

NewgenIVF Group has signed an agreement to act as the worldwide agent for tokenizing the World Chinese Museum’s private...

CorMedix posted preliminary third-quarter 2025 results showing more than $100 million in net revenue, at least $85 million from...

OGRD Alliance is expanding its PLPC-DB phospholipoproteomic module and its Oncovix documentation program from Dubai into Asia and the...